Later studies using two different mouse models of AD based on the transgenic expression of human APP (APP/PS1 mice and J20 mice, thoroughly described below) confirmed that P2X7R upregulation in activated microglial was parallel with AD progression (Lee et al., 2011; Martinez-Frailes et al., 2019). Here, PSEN1 is linked to Alzheimer disease.